• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC SUNNYVALE/APTUS ENDOSYSTEMS ENDO ANCHOR SYSTEM - HELI-FX TAA; LASER THERAPY PRODUCT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC SUNNYVALE/APTUS ENDOSYSTEMS ENDO ANCHOR SYSTEM - HELI-FX TAA; LASER THERAPY PRODUCT Back to Search Results
Model Number HA-18-114
Device Problems Break (1069); Device Dislodged or Dislocated (2923)
Patient Problem Injury (2348)
Event Date 03/12/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A heli-fx applier and endoanchors were used in the endovascular treatment of a patient in conjunction with a valiant stent graft system for a thoracic aortic aneurysm.It was reported during the index procedure that the valiant was being implanted distal to a previously implanted stent graft to extend the seal zone in a reintervention procedure.2 endoanchors were implanted in an ap direction successfully but on implantation of the 3rd endoanchor, it appeared to bounce off the m stent and was partially deployed into the stent graft.It was observed that a portion of the endoanchor broke off and this was successfully snared out.Another endoanchor was deployed and when imaged this appeared to have been implanted outside of the stent graft.After a total of 10 endoanchors had been implanted.A review was performed to ensure no stent graft tear was present after the observation of the stent graft had been deployed outside of the stent graft but there was no tear or leak observed.As per the physician the cause of the event cannot be determined.No additional clinical sequelae were reported and the patient is fine.
 
Manufacturer Narrative
Film evaluation summary: the cause of the events could not be determined from the films provided.The cause of the reported reduced distal seal zone of the initially implanted valiant could not be determined.Review of a limited angiogram study during the 2015 implant revealed that a single valiant stent graft had been implanted in the patient¿s thoracic.Multiple endoanchors (>10) also were seen having been implanted into the distal 3cm length of the valiant.The distal stent graft position relative to the visceral vessels could not be determined, and no clear endoleak or any other issues were observed from the limited study returned.The returned 2018 pre-intervention images were non-contrast; therefore, no assessment of any potential endoleak could be performed, and the distal stent graft position relative to the visceral vessels also could not be determined.The exact cause of the reported partial endoanchor deployment and fracture also could not be determined from the films.Angiograms during the segments of the intervention were returned.Several non-contrast still images revealed that an additional valiant stent graft had been implanted, extending several cm¿s distal to the previously implanted device.Two (2) endoanchors were initially seen having been deployed, and the guide and likely single mal-deployed anchor were then seen along the patient¿s right side of the distal stent graft.The guide was angulated ~90 deg to the right, and after straightening the guide another image showed what appeared to be an anchor positioned outside the right side of the stent graft, as well as portion of another (or same) anchor positioned near the distal stent graft margin.Cine images during anchor deployment were not seen, and it is unclear if these mal-deployed anchors were implanted in the aorta or floating.Final angiogram during contrast injection revealed no clear endoleak or any other obvious issues.Analysis of the returned films did not reveal any device or anatomical characteristics that could explain the reported event, and lack of ct¿s did not allow for a thorough assessment of the patient¿s anatomy.A device issue cannot be ruled out as a potential cause of the partial endoanchor deployment and fracture.The guide and/or broken anchor is expected to be returned for analysis, and the results will be summarized in a separate report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Device evaluation summary: there was no damage observed to the device or the endoanchor housing.Visual inspection confirmed there was no endoanchor loaded in the applier.The handle was opened, and no fluid or blood was observed within the handle.No corrosion was observed to the circuit board or connector pins.All wires and connectors within the handle appeared to be intact and properly connected.The battery was removed and measured 7.19v.A new battery was attached, and the unit powered up with the blue error light flashing, the forward light unresponsive and the back light flashing.The device was restarted in factory mode with the blue error light on, forward light flashing, back light on.The inner tip mechanism did not rotate when the forward and back buttons were pressed.However, the applier shaft did rotate, and twisting was observed on the shaft.It was not possible to flush water through the shaft indicating the presence of congealed blood within the device.The shaft was cut back; congealed blood was visible inside the shaft.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDO ANCHOR SYSTEM - HELI-FX TAA
Type of Device
LASER THERAPY PRODUCT
Manufacturer (Section D)
MEDTRONIC SUNNYVALE/APTUS ENDOSYSTEMS
271 gibraltar dr
sunnyvale
california 94089
Manufacturer (Section G)
MEDTRONIC SUNNYVALE/APTUS ENDOSYSTEMS
271 gibraltar dr
sunnyvale
california 94089
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key7403436
MDR Text Key104588470
Report Number2953200-2018-00509
Device Sequence Number1
Product Code OTD
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K140036
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 10/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2019
Device Model NumberHA-18-114
Device Catalogue NumberHA-18-114
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/27/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/04/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/02/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-